Báo cáo tài chính

DBM · CTCP Dược - Vật tư Y Tế Đăk Lăk

Báo cáo tài chính gốc theo dòng/kỳ (KQKD · Cân đối · Lưu chuyển tiền tệ).

Item	2025	2024	2023	2022
Revenue	219.9	213.4	236.7	258.9
Revenue Deductions	0.6	0.3	0.3	1.1
Net Revenue	219.3	213.0	236.4	257.8
Cost of Goods Sold	196.5	193.2	212.8	229.4
Gross Profit	22.8	19.8	23.5	28.3
Financial Income	3.1	2.9	2.6	1.9
Financial Expenses	0.4	0.4	0.4	0.5
Interest Expense	—	0.0	0.0	0.0
Share of Associates and Joint Ventures	—	0.0	0.0	0.0
Selling Expenses	11.4	11.0	11.3	13.6
General and Administrative Expenses	8.8	8.7	8.5	9.7
Operating Profit	5.2	2.6	5.9	6.3
Other Income	0.4	0.7	1.2	1.5
Other Expenses	0.0	0.0	0.0	0.0
Other Profit	0.4	0.7	1.1	1.5
Profit Before Tax	5.7	3.3	7.0	7.9
Current Income Tax Expense	1.0	0.5	1.4	1.4
Deferred Income Tax Expense	—	0.0	0.0	0.1
Net Income	4.6	2.8	5.6	6.3
Non-controlling Interest	—	0.0	0.0	0.0
Profit Attributable to Parent	4.6	2.8	5.6	6.3
Earnings per Share	2,392.00	1,439.00	2,894.00	3,254.00
Diluted EPS	2,392.00	1,439.00	2,894.00	3,254.00

Item	2025	2024	2023	2022
A. SHORT-TERM ASSETS (100=110+120+130+140+150)	100.3	96.2	101.5	105.2
I. Cash and cash equivalents	12.6	11.1	8.9	14.8
1. Cash	8.6	11.1	8.9	9.8
2. Cash equivalents	4.0	0.0	0.0	5.0
II. Short-term financial investments	41.0	36.5	36.3	28.8
1. Available for sale securities	—	0.0	0.0	0.0
2. Provision for diminution in value of available for sale securities (*)	—	0.0	0.0	0.0
3. Held to maturity investments	41.0	36.5	36.3	28.8
III. Short-term receivables	19.8	24.3	29.0	33.4
1. Short-term trade accounts receivable	20.4	24.6	28.9	33.4
2. Short-term prepayments to suppliers	0.0	0.2	0.4	0.5
3. Short-term inter-company receivables	—	0.0	0.0	0.0
4. Construction contract progress receipts due from customers	—	0.0	0.0	0.0
5. Short-term loan receivables	—	0.0	0.0	0.0
6. Other short-term receivables	0.2	0.3	0.2	0.1
7. Provision for short-term doubtful debts (*)	-0.7	-0.8	-0.4	-0.5
8. Assets awaiting resolution	—	0.0	0.0	0.0
IV. Inventories	26.8	24.2	27.0	27.9
1. Inventories	27.2	24.5	27.3	28.0
2. Provision for decline in value of inventories	-0.3	-0.3	-0.3	-0.1
V. Other short-term assets	0.1	0.1	0.2	0.1
1. Short-term prepayments	0.1	0.1	0.2	0.1
2. Value added tax to be reclaimed	0.0	0.0	0.0	0.0
3. Taxes and other receivables from state authorities	—	0.0	0.0	0.0
4. Government bonds	—	0.0	0.0	0.0
5. Other short-term assets	—	0.0	0.0	0.0
B. LONG-TERM ASSETS (200=210+220+240+250+260+270)	5.3	4.5	4.5	4.0
I. Long-term receivables	—	0.0	0.0	0.0
1. Long-term trade receivables	—	0.0	0.0	0.0
2. Long-term prepayments to suppliers	—	0.0	0.0	0.0
3. Capital at inter-company	—	0.0	0.0	0.0
4. Long-term inter-company receivables	—	0.0	0.0	0.0
5. Long-term loan receivables	—	0.0	0.0	0.0
6. Other long-term receivables	—	0.0	0.0	0.0
7. Provision for long-term doubtful debts	—	0.0	0.0	0.0
II. Fixed assets	4.8	4.0	4.0	3.5
1. Tangible fixed assets	4.4	3.5	3.3	2.6
- Cost	20.6	19.1	18.6	17.5
- Accumulated depreciation	-16.2	-15.6	-15.4	-14.9
2. Financial leased fixed assets	—	0.0	0.0	0.0
- Cost	—	0.0	0.0	0.0
- Accumulated depreciation	—	0.0	0.0	0.0
3. Intangible fixed assets	0.4	0.5	0.7	0.9
- Cost	1.5	1.5	1.5	1.5
- Accumulated depreciation	-1.1	-1.0	-0.8	-0.6
III. Investment properties	—	0.0	0.0	0.0
- Cost	—	0.0	0.0	0.0
- Accumulated depreciation	—	0.0	0.0	0.0
IV. Long-term assets in progress	—	0.0	0.0	0.0
1. Long-term production in progress	—	0.0	0.0	0.0
2. Construction in progress	—	0.0	0.0	0.0
V. Long-term financial investments	0.5	0.5	0.5	0.5
1. Investments in subsidiaries	—	0.0	0.0	0.0
2. Investments in associates, joint-ventures	—	0.0	0.0	0.0
3. Investments in other entities	0.5	0.5	0.5	0.5
4. Provision for diminution in value of long-term investments	—	0.0	0.0	0.0
5. Held to maturity investments	—	0.0	0.0	0.0
6. Other long-term investments	—	0.0	0.0	0.0
VI. Other long-term assets	—	0.0	0.0	0.0
1. Long-term prepayments	—	0.0	0.0	0.0
2. Deferred income tax assets	—	0.0	0.0	0.0
3. Long-term equipment, supplies, spare parts	—	0.0	0.0	0.0
4. Other long-term assets	—	0.0	0.0	0.0
5. Goodwill	—	0.0	0.0	0.0
VII. Goodwill (before 2015)	—	0.0	0.0	0.0
TOTAL ASSETS (280=100+200)	105.6	100.7	106.0	109.1
A. LIABILITIES (300=210+330)	36.0	33.0	36.7	41.0
I. Short -term liabilities	36.0	33.0	36.7	41.0
1. Short-term trade accounts payable	31.5	29.5	32.2	33.5
2. Short-term advances from customers	0.0	0.0	0.0	0.0
3. Taxes and other payables to state authorities	0.9	0.5	0.8	0.9
4. Payable to employees	1.8	1.6	2.6	4.6
5. Short-term acrrued expenses	0.5	0.6	0.6	0.9
6. Short-term inter-company payables	—	0.0	0.0	0.0
7. Construction contract progress payments due to suppliers	—	0.0	0.0	0.0
8. Short-term unearned revenue	0.5	0.2	0.2	0.3
9. Other short-term payables	0.3	0.2	0.3	0.4
10. Short-term borrowings and financial leases	—	0.0	0.0	0.0
11. Provision for short-term liabilities	—	0.0	0.0	0.0
12.. Bonus and welfare fund	0.5	0.5	0.1	0.3
13. Price stabilization fund	—	0.0	0.0	0.0
14. Government bonds	—	0.0	0.0	0.0
II. Long-term liabilities	—	0.0	0.0	0.0
1. Long-term trade payables	—	0.0	0.0	0.0
2. Long-term advances from customers	—	0.0	0.0	0.0
3. Long-term acrrued expenses	—	0.0	0.0	0.0
4. Inter-company payables on business capital	—	0.0	0.0	0.0
5. Long-term inter-company payables	—	0.0	0.0	0.0
6. Long-term unearned revenue	—	0.0	0.0	0.0
7. Other long-term liabilities	—	0.0	0.0	0.0
8. Long-term borrowings and financial leases	—	0.0	0.0	0.0
9. Convertible bonds	—	0.0	0.0	0.0
10. Preferred stock (Debts)	—	0.00	0.00	0.00
11. Deferred income tax liabilities	—	0.0	0.0	0.0
12. Provision for long-term liabilities	—	0.0	0.0	0.0
13. Fund for technology development	—	0.0	0.0	0.0
14. Provision for severance allowances	—	0.0	0.0	0.0
B. OWNER'S EQUITY (400=410+430)	69.5	67.7	69.3	68.1
I. Owner's equity	69.5	67.7	69.3	68.1
1. Owner's capital	19.4	19.4	19.4	19.4
- Common stock with voting right	19,415,880,000.00	19,415,880,000.00	19,415,880,000.00	19,415,880,000.00
- Preferred stock	—	0.00	0.00	0.00
2. Share premium	—	0.0	0.0	0.0
3. Convertible bond option	—	0.0	0.0	0.0
4. Other capital of owners	—	0.0	0.0	0.0
5. Treasury shares	-40,000.00	-40,000.00	-40,000.00	-40,000.00
6. Assets revaluation differences	—	0.0	0.0	0.0
7. Foreign exchange differences	—	0.0	0.0	0.0
8. Investment and development fund	37.6	37.6	37.3	35.5
9. Fund to support corporate restructuring	—	0.0	0.0	0.0
10. Other funds from owner's equity	1.3	1.3	1.3	1.3
11. Undistributed earnings after tax	11.2	9.3	11.2	11.9
- Accumulated retained earning at the end of the previous period	6.6	6.6	5.6	5.6
- Undistributed earnings in this period	4.6	2.8	5.6	6.3
12. Reserves for investment in construction	—	0.0	0.0	0.0
13. Minority's interest	—	0.0	0.0	0.0
14. Financial reserves	—	0.0	0.0	0.0
II. Other resources and funds	—	0.0	0.0	0.0
1. Subsidized not-for-profit funds	—	0.0	0.0	0.0
2. Funds invested in fixed assets	—	0.0	0.0	0.0
C. MINORITY'S INTEREST	—	0.0	0.0	0.0
TOTAL OWNER'S EQUITY AND LIABILITIES (440=300+400+500)	105.6	100.7	106.0	109.1

Item	2025	2024	2023	2022
Profit Before Tax	5.7	3.3	7.0	7.9
Depreciation of Fixed Assets and Investment Property	0.7	0.7	0.6	0.7
Provision (Increase)/Reversal	-0.1	0.4	0.1	0.1
FX Gain/Loss from Revaluation of Monetary Items	—	0.0	0.0	0.0
Gain/Loss from Investment Activities	-2.7	-2.6	-2.2	-1.4
Interest Expense	—	0.0	0.0	0.0
Gain/Loss on Disposal of Fixed Assets	—	0.0	0.0	0.0
Interest Income and Dividends	—	0.0	0.0	0.0
Amortization of Goodwill	—	0.0	0.0	0.0
Other Adjustments	—	0.0	0.0	0.0
Operating Profit Before Changes in Working Capital	3.7	1.9	5.5	7.3
Increase/(Decrease) in Receivables	4.6	4.3	4.5	-3.0
Increase/(Decrease) in Inventory	-2.7	2.8	0.8	-2.3
Increase/(Decrease) in Payables (Excl. Interest and CIT)	2.5	-3.8	-4.0	8.9
Increase/(Decrease) in Prepaid Expenses	0.0	0.2	-0.1	-0.1
Changes in Trading Securities	—	0.0	0.0	0.0
Interest Paid	—	-0.0	-0.0	0.0
Corporate Income Tax Paid	-0.5	-0.8	-1.5	-1.8
Other Operating Receipts	—	0.0	0.0	0.0
Other Operating Payments	-0.6	-0.7	-1.4	-1.2
Net Cash Flow from Operating Activities	7.0	3.7	3.8	7.7
Payments for Fixed Assets and Other Long-term Assets	-1.5	-0.7	-1.2	-0.1
Proceeds from Disposal of Fixed Assets and Long-term Assets	—	0.0	0.0	0.0
Loans and Purchases of Debt Instruments	-30.0	-28.0	-21.5	-11.0
Receipts from Loan Repayments and Sale of Debt Instruments	25.5	27.8	14.0	3.0
Investments in Other Entities	—	0.0	0.0	0.0
Proceeds from Investments in Other Entities	—	0.0	0.0	0.0
Dividends and Interest Income Received	2.7	2.5	2.2	1.4
Increase/(Decrease) in Term Deposits	—	0.0	0.0	0.0
Acquisition of Non-controlling Interests	—	0.0	0.0	0.0
Other Investing Receipts	—	0.0	0.0	0.0
Other Investing Payments	—	0.0	0.0	0.0
Net Cash Flow from Investing Activities	-3.3	1.7	-6.4	-6.7
Proceeds from Equity Issuance and Capital Contributions	—	0.00	0.00	0.00
Share Repurchases	—	0.00	0.00	0.00
Proceeds from Borrowings	—	0.0	0.0	0.0
Repayment of Borrowings	—	0.0	0.0	0.0
Repayment of Finance Leases	—	0.0	0.0	0.0
Dividends Paid	-2.2	-3.3	-3.3	-3.3
Other Financing Receipts	—	0.0	0.0	0.0
Other Financing Payments	—	0.0	0.0	0.0
Net Cash Flow from Financing Activities	-2.2	-3.3	-3.3	-3.3
Net Cash Flow During the Period	1.5	2.1	-5.9	-2.2
Cash and Cash Equivalents at Beginning of Period	11.1	8.9	14.8	17.0
FX Difference from Revaluation	—	0.0	0.0	0.0
Cash and Cash Equivalents at End of Period	12.6	11.1	8.9	14.8

Item	Q4'25
Profit Before Tax	5.7
Depreciation of Fixed Assets and Investment Property	0.7
Provision (Increase)/Reversal	-0.1
Gain/Loss from Investment Activities	-2.7
Operating Profit Before Changes in Working Capital	3.7
Increase/(Decrease) in Receivables	4.6
Increase/(Decrease) in Inventory	-2.7
Increase/(Decrease) in Payables (Excl. Interest and CIT)	2.5
Increase/(Decrease) in Prepaid Expenses	0.0
Corporate Income Tax Paid	-0.5
Other Operating Payments	-0.6
Net Cash Flow from Operating Activities	7.0
Payments for Fixed Assets and Other Long-term Assets	-1.5
Loans and Purchases of Debt Instruments	-30.0
Receipts from Loan Repayments and Sale of Debt Instruments	25.5
Dividends and Interest Income Received	2.7
Net Cash Flow from Investing Activities	-3.3
Dividends Paid	-2.2
Net Cash Flow from Financing Activities	-2.2
Net Cash Flow During the Period	1.5
Cash and Cash Equivalents at Beginning of Period	11.1
Cash and Cash Equivalents at End of Period	12.6

Giải mã BCTC

Điểm nhấn trong BCTC của CTCP Dược - Vật tư Y Tế Đăk Lăk (DBM) mà bạn nên biết

On a Năm 2025 basis, DBM is showing some signs of improvement versus the same period, but the current picture is not yet broad enough to confirm a stronger trend — the growth momentum has held across consecutive periods.

Want to know what to do next with this momentum? Talk to an advisor

Tiếp theo: Chuỗi số liệu & so sánh ngành → Tổng quan· Bóc tách BCTC· Nhận định